Johnson & Johnson
Johnson & Johnson
J&J to end sales of baby powder with talc globally next year
Johnson & Johnson is pulling baby powder containing talc worldwide next year after it did the same in the U.S. and Canada amid thousands of...
Russians buy last goods from H&M, IKEA as stores wind down
MOSCOW (AP) — Russians are snapping up Western fashion and furniture this week as H&M and IKEA sell off the last of their inventory in Russia,...
Nonprofits launch $100M plan to support local health workers
A new philanthropic project hopes to invest $100 million in 10 countries, mostly in Africa, by 2030 to support 200,000 community health workers,...
Is Investing in Shroom Stocks a Good Idea?
Shroom stocks, otherwise known as psychedelic stocks, present an early-stage investment opportunity that could result in mainstream health treatments.
As Myocarditis Debate Rages On, Heart Disease Cases Mount
Few had heard of myocarditis before the pandemic, but now it’s a serious worry making global headlines. One company is hoping to treat it.
CDC advisers endorse more traditional Novavax COVID shot
U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax -- a more traditional kind of vaccine, influential...
Strong Q2 at J&J, but outlook cut again due to dollar's rise
AP Health Writer (AP) — Johnson & Johnson rode growing sales of the cancer treatment Darzalex and other key drugs to a better-than-expected second...
Asian shares slip as investors eye inflation, earnings
TOKYO (AP) — Asian shares were mostly lower Tuesday, as investors weighed oil prices, inflation worries and corporate earnings.
What is Life Sciences and Should You Invest?
Investment in Life Sciences has exploded in recent years. But what is Life Sciences? Read on to discover the nature-based opportunities in this field.
JNJ, HAL, AAL, CLF, TSCO: Earnings Preview
This week we preview earnings for Johnson & Johnson (NYSE: JNJ), Halliburton (NYSE: HAL), American Airlines (NASDAQ: AAL), Cleveland-Cliffs (NYSE:...
US regulators OK new COVID-19 shot option from Novavax
The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared shots for adults.
Asian shares gain as investors shrug off downbeat data
BANGKOK (AP) — Shares were higher in Asia on Friday, despite data suggesting economies are slowing. The advance tracked gains on Wall Street, where...
Kellogg to split into 3; snacks, cereals, plant-based food
Kellogg Co., the maker of Frosted Flakes, Rice Krispies and Eggo, will split into three companies focused on cereals, snacks and plant-based foods.
FDA advisers back Novavax COVID shots as 4th US option
American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on...
Novavax hopes its COVID shot wins over FDA, vaccine holdouts
GAITHERSBURG, Md. (AP) — Americans may soon get a new COVID-19 vaccine option -- shots made with a more tried-and-true technology than today’s...
Tentative $161.5M settlement reached in WVa opioid trial
CHARLESTON, W.Va. (AP) — Attorneys for the state of West Virginia and two remaining pharmaceutical manufacturers have reached a tentative $161.5...